Skip to content
MarketScale
‹ Back to IndustriesHealthcare

InstiCollect Animated Explainer

Start improving your cashflow today with InstiCollect. InstiCollect serves as an automatic debt collector to help you retrieve payments faster by utilizing a combination of phone calls, letters and emails optimized for quick response rates. It is a simplified and curated approach to help your bottom line and boost profits. This solution is ideal for…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Start improving your cashflow today with InstiCollect. InstiCollect serves as an automatic debt collector to help you retrieve payments faster by utilizing a combination of phone calls, letters and emails optimized for quick response rates. It is a simplified and curated approach to help your bottom line and boost profits. This solution is ideal for medical and dental debt as well as rent recovery and other applications. IC System is the collection agency of choice for small businesses looking for a premier debt collector partner.

For more information, visit https://www.icsystem.com/.

Video TranscriptExpand ↓

Are you looking for a faster way to get your past due accounts to pay? IC System has simplified small business debt collection with InstiCollect. You can skip the sales people with InstiCollect and start using IC System's collection services today. With InstiCollect, we use dynamic touchpoints to reach your past due accounts, including a combination of phone calls, letters and emails to communicate with consumers in the medium that they prefer. Each account you send to IC System receives our proven collection strategies one or more letters up to 31 outbound phone attempts from our US based agents. Credit reporting on eligible accounts. Skip tracing and responsive collection strategies that find smarter ways to help your bottom line. If your account isn't collected after 180 days, the collection activity isn't over. We offer additional calls and letters on qualifying accounts, credit monitoring for changes on consumer's credit profile that may lead to resolution and attorney referral services to create urgency with calls and letters from attorney on IC System's behalf. Best of all, our ethical award winning collection practices are rooted in empathy and compassion. We survey thousands of past-due consumers and patients who work with the system, and 99% feel that they have been treated professionally by our collection representatives. Sign up for InstiCollect today with only a $75 setup fee. After that, it's just a competitive 35% contingency fee on any payments while the account is with IC System. So what are you waiting for? Get started with InstiCollect and start improving your cash flow today.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended AstraZeneca and Daiichi Sankyo’s Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly is investing $6.5 billion in a Houston manufacturing facility set to open around 2030, primarily to scale production of Foundayo, its oral GLP-1 treatment. The project signals a broader shift in U.S. pharmaceutical manufacturing reshoring and underscores the supply chain challenge of forecasting demand and building capacity years in advance for breakthrough therapeutics.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512